Cassava Sciences Inc Financial Statements (SAVA)
|
|
|
|
Report date
|
|
|
14.08.2025 |
12.11.2025 |
12.03.2026 |
07.05.2026 |
29.07.2026 |
|
07.05.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Operating Income, bln rub |
|
|
-45.4 |
-11.9 |
-13.6 |
-11.2 |
-9.39 |
|
-70.8 |
|
EBITDA, bln rub |
? |
|
-13.9 |
-10.6 |
-48.6 |
-10.9 |
-8.86 |
|
-73.1 |
|
Net profit, bln rub |
? |
|
-44.2 |
-10.8 |
-12.5 |
-10.3 |
-8.60 |
|
-77.9 |
|
|
OCF, bln rub |
? |
|
-4.95 |
-6.22 |
-9.75 |
-8.88 |
-3.86 |
|
-29.8 |
|
CAPEX, bln rub |
? |
|
0.000 |
0.080 |
0.501 |
0.000 |
0.021 |
|
0.581 |
|
FCF, bln rub |
? |
|
-4.95 |
-6.30 |
-10.2 |
-8.88 |
-3.88 |
|
-30.4 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
40.3 |
11.7 |
32.5 |
10.9 |
9.39 |
|
95.6 |
|
Cost of production, bln rub |
|
|
5.12 |
0.200 |
19.0 |
0.243 |
0.000 |
|
24.3 |
|
R&D, bln rub |
|
|
5.12 |
3.96 |
3.85 |
4.54 |
3.30 |
|
17.5 |
|
Interest expenses, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Assets, bln rub |
|
|
135.4 |
129.7 |
118.4 |
108.4 |
103.9 |
|
108.4 |
|
Net Assets, bln rub |
? |
|
88.0 |
81.6 |
74.4 |
68.1 |
63.6 |
|
68.1 |
|
Debt, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Cash, bln rub |
|
|
112.4 |
106.1 |
95.5 |
86.6 |
82.7 |
|
86.6 |
|
Net debt, bln rub |
|
|
-112.4 |
-106.1 |
-95.5 |
-86.6 |
-82.7 |
|
-86.6 |
|
|
Ordinary share price, rub |
|
|
1.81 |
2.91 |
1.98 |
1.69 |
1.19 |
|
1.32 |
|
Number of ordinary shares, mln |
|
|
48.3 |
48.3 |
48.3 |
48.3 |
48.3 |
|
48.3 |
|
|
Market cap, bln rub |
|
|
87 |
141 |
96 |
82 |
57 |
|
64 |
|
EV, bln rub |
? |
|
-25 |
34 |
0 |
-5 |
-25 |
|
-23 |
|
Book value, bln rub |
|
|
88 |
82 |
74 |
68 |
64 |
|
68 |
|
|
EPS, rub |
? |
|
-0.92 |
-0.22 |
-0.26 |
-0.21 |
-0.18 |
|
-1.61 |
|
FCF/share, rub |
|
|
-0.10 |
-0.13 |
-0.21 |
-0.18 |
-0.08 |
|
-0.63 |
|
BV/share, rub |
|
|
1.82 |
1.69 |
1.54 |
1.41 |
1.32 |
|
1.41 |
|
|
FCF conversion, % |
|
|
35.7% |
59.4% |
21.1% |
81.3% |
43.7% |
|
41.6% |
|
FCF yield, % |
? |
|
-109.7% |
-59.7% |
-34.3% |
-37.2% |
-51.0% |
|
-47.6% |
|
ROE, % |
? |
|
-140.0% |
-130.0% |
-122.3% |
-114.3% |
-66.5% |
|
-114.3% |
|
ROA, % |
? |
|
-91.0% |
-81.7% |
-76.9% |
-71.9% |
-40.7% |
|
-71.9% |
|
|
P/E |
? |
|
-0.71 |
-1.33 |
-1.05 |
-1.05 |
-1.36 |
|
-0.82 |
|
P/FCF |
|
|
-0.91 |
-1.67 |
-2.91 |
-2.69 |
-1.96 |
|
-2.10 |
|
P/BV |
? |
|
0.99 |
1.72 |
1.29 |
1.20 |
0.90 |
|
0.94 |
|
EV/EBITDA |
? |
|
0.29 |
-0.53 |
0.00 |
0.06 |
0.32 |
|
0.31 |
|
Debt/EBITDA |
|
|
1.31 |
1.63 |
1.01 |
1.03 |
1.05 |
|
1.18 |
|
|
R&D/CAPEX, % |
|
|
|
4 944% |
769.1% |
|
15 729% |
|
3 007% |
|
| Cassava Sciences Inc shareholders |
